Corrigendum to ‘Arachidonate 5-Lipoxygenase (ALOX5) gene polymorphism is associated with Alzheimer's disease and body mass index [Šerý et al., J. Neurol. Sci. 362 (2016) 27–32]

Omar Šerý (1) , Lydia Hlinecká (1) , Jana Povová (2) , Ondřej Bonczek (1) , Tomáš Zeman (1) , Vladimír Janout (2) , Petr Ambroz (2) , Naim Akhtar Akhtar Khan (3, 4) , Vladimir J. Balcar (5, 6)

1 MUNI - Masaryk University [Brno]
2 Department of Epidemiology and Public Health [university of Ostrava]
3 NUTox - Physiologie de la Nutrition et Toxicologie (NUTox) (U866, Lipides et nutrition, équipe 7)
4 LNC - Lipides - Nutrition - Cancer (U866)
5 Discipline of Anatomy and Histology {University of Sydney]
6 Bosch Institute [Sydney]

Mots clés: Leukotrienes; Genetics; Inflammation; Curcumin; Arachidonic acid; Alzheimer's disease; Polymorphism; Caffeic acid; Association; FLAP; Single-Nucleotide polymorphisms; Mouse model; Activating protein; Neuronal 5-lipoxygenase; Amyloidotic phenotype; Dna methylation; Adipose-tissue; Messenger-rna; Risk-factors; Putative role

Domaines: Neurosciences [q-bio.NC]

Omar Šerý, Lydia Hlinecká, Jana Povová, Ondřej Bonczek, Tomáš Zeman, et al.. Corrigendum to ‘Arachidonate 5-Lipoxygenase (ALOX5) gene polymorphism is associated with Alzheimer's disease and body mass index [Šerý et al., J. Neurol. Sci. 362 (2016) 27–32]. 2016, pp.135. ⟨10.1016/j.jns.2016.05.008⟩. ⟨hal-01435165⟩